Inclusion Criteria:~* Subjects with Probable Alzheimer's disease~* Mini-Mental State Examination (MMSE) score
of 14 to 24 inclusive at screening and a CDR-SB score ≥2 at the screening assessment~* Modified Hachinski
Ischemic Score (mHIS) ≤4 at screening~* Female subjects are ≥1 year post-menopausal or are surgically sterile~*
Caregiver available; if not living in the same household, caregiver sees subject at least four times each
week~* Subject living at home, senior residential setting, or an institutional setting without the need for
continuous nursing care~* General health status acceptable for participation in a 24 week clinical trial be
administered~
